Skip to content
BidBenchmark

Indefinite delivery vehicle

NOVARTIS PHARMACEUTICALS CORPORATION

PLUVICTO
PIID
36C25026A0001
Award key
CONT_IDV_36C25026A0001_3600
Recipient UEI
NG61ZA8TADW3
Parent award
CONT_IDV_36F79720D0180_3600
Source as of
—
Current award value
—3
Obligated to date
$02
Potential with options
$7,480,0003
Awarding agency
Department of Veterans AffairsDepartment of Veterans Affairs
Place of performance
—
Set-aside
None
Pricing
Firm Fixed Price
Competition
Full and Open Competition1 offers received
Period of performance
Oct 1, 2025 — Sep 30, 2030
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Oct 1, 2025Initial award$0.00—
P00001Dec 17, 2025B$0.00—
P00002Sep 10, 2026G$0.00—

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.gov—Sep 12, 2026usaspending_contract_csv@2026.08.2177673009d58
contractor_idUSAspending.gov—Sep 12, 2026usaspending_contract_csv@2026.08.2177673009d58
current_award_valueUSAspending.gov—Sep 12, 2026usaspending_contract_csv@2026.08.2177673009d58
naics_codeUSAspending.gov—Sep 12, 2026usaspending_contract_csv@2026.08.2177673009d58
potential_award_valueUSAspending.gov—Sep 12, 2026usaspending_contract_csv@2026.08.2177673009d58
psc_codeUSAspending.gov—Sep 12, 2026usaspending_contract_csv@2026.08.2177673009d58
total_obligatedUSAspending.gov—Sep 12, 2026usaspending_contract_csv@2026.08.2177673009d58

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 3 transaction records parsed from USAspending.gov, retrieved Sep 12, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
36C25026A0001 — NOVARTIS PHARMACEUTICALS CORPORATION · BidBenchmark